RECRUITING

Advanced Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The overarching goal of this study is to develop a peer-based care coordination intervention for individuals with Hepatitis C Virus (HCV) who were recently released from correctional settings to promote linkage to and retention in HCV care. The investigators will assess the existing barriers and facilitators of HCV treatment initiation, HCV treatment completion, and sustained virologic response among individuals recently released from a U.S. jail or prisons in a randomized control trial. This study will assess the feasibility and process measures of a peer-enhanced HCV care coordination intervention among recently incarcerated individuals.

Official Title

HCV-ACCELERATE Advanced Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants

Quick Facts

Study Start:2021-12-17
Study Completion:2026-06
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04701437

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * currently incarcerated or recently released from a U.S. jail or prison (6 months)
  2. * Chronic HCV with documented detectable viral load
  3. * 18 years old
  4. * Fluent in English or Spanish
  5. * Resident of the Upstate area of South Carolina
  1. * Unable to sign informed consent
  2. * Life expectancy of less than 1 year
  3. * Plans to relocate from the Upstate area of South Carolina in the next 6 months

Contacts and Locations

Study Contact

Matthew Akiyama, MD
CONTACT
718-920-7175
makiyama@montefiore.org
Lindsey Riback, MPH
CONTACT
201-372-4089
lindsey.riback@einsteinmed.org

Principal Investigator

Matthew Akiyama, MD
PRINCIPAL_INVESTIGATOR
Montefiore Medical Center/Albert Einstein College of Medicine
Alain Litwin, MD
PRINCIPAL_INVESTIGATOR
Prisma Health-Upstate

Study Locations (Sites)

Prisma Health-Upstate
Greenville, South Carolina, 29605
United States

Collaborators and Investigators

Sponsor: Montefiore Medical Center

  • Matthew Akiyama, MD, PRINCIPAL_INVESTIGATOR, Montefiore Medical Center/Albert Einstein College of Medicine
  • Alain Litwin, MD, PRINCIPAL_INVESTIGATOR, Prisma Health-Upstate

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-12-17
Study Completion Date2026-06

Study Record Updates

Study Start Date2021-12-17
Study Completion Date2026-06

Terms related to this study

Keywords Provided by Researchers

  • recently incarcerated
  • Hepatitis C
  • peer mentor

Additional Relevant MeSH Terms

  • Hepatitis C